发明名称 |
Compositions and methods for treating an intervertebral disc using bulking agents or sealing agents |
摘要 |
Effective compositions and methods for treating an intervertebral disc are provided. The compositions and methods comprise a bulking agent or sealing agent, the bulking agent or sealing agent adapted to be administered at or within the intervertebral disc, the bulking or sealing agent having a drug depot comprising an effective amount of a therapeutic agent disposed therein, wherein the drug depot is capable of releasing an effective amount of the therapeutic agent over a period of at least one day. |
申请公布号 |
US9050274(B2) |
申请公布日期 |
2015.06.09 |
申请号 |
US201012695904 |
申请日期 |
2010.01.28 |
申请人 |
Warsaw Orthopedic, Inc. |
发明人 |
Haddock Sean M.;Drapeau Susan J.;Simonton Thomas Andrew |
分类号 |
A61K31/60;A61K31/165;A61K31/00;A61K9/00;A61K47/34 |
主分类号 |
A61K31/60 |
代理机构 |
Sorell Lenna & Schmidt LLP |
代理人 |
Sorell Lenna & Schmidt LLP |
主权项 |
1. A composition for treating an intervertebral disc in a patient in need of such treatment, the composition comprising a bulking agent or sealing agent comprising polyvinylalcohol in the form of fibers, the bulking or sealing agent comprises pendent chains comprising crosslinkable groups of N-acrylamidoacetaldehyde dimethyl acetal in an amount of 6 to 21 crosslinkers per polyvinylalcohol, the bulking agent or sealing agent adapted to be administered at or within the intervertebral disc to treat leakage and/or augment the intervertebral disc, the bulking or sealing agent having a plurality of drug depots that are uniformly distributed within the bulking or sealing agent, the drug depots each comprising an effective amount of a therapeutic agent disposed therein, wherein the drug depots each comprise a biopolymer comprising polylactide (PLA) and polyglycolide (PGA), the biopolymer comprising at least 80% PLA, the remainder of the biopolymer being PGA, wherein the biopolymer comprises at least 50 wt % of the composition, and the drug depots are capable of releasing an effective amount of the therapeutic agent over a period of 3 to 45 days. |
地址 |
Warsaw IN US |